(SOL) Emeren - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US75971T3014
SOL: Solar, Power, Projects, Electricity
Emeren Group Ltd, together with its subsidiaries, develops, builds, and sells solar power projects. It owns and operates 3-gigawatt pipeline of projects and independent power producer assets, as well as a 10-gigawatt pipeline of storage pipeline. The company develops community solar gardens; and sells project rights. In addition, it engages in engineering design; procurement of solar modules; balance-of-system components and other components; and construction contracting and management services. Further, the company generates and sells electricity. It operates in China, the United States, the United Kingdom, Germany, France, Poland, Italy, and Hungary. The company was formerly known as ReneSola Ltd and changed its name to Emeren Group Ltd in January 2023. Emeren Group Ltd was founded in 2005 and is headquartered in Norwalk, Connecticut., Web URL: https://emeren.com
Additional Sources for SOL Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SOL Stock Overview
| Market Cap in USD | 90m |
| Sector | Technology |
| Industry | Solar |
| GiC Sub-Industry | Construction & Engineering |
| IPO / Inception | 2008-01-29 |
SOL Stock Ratings
| Growth 5y | -6.78% |
| Fundamental | -48.6% |
| Dividend | 0.0% |
| Rel. Strength Industry | -29.4 |
| Analysts | 4/5 |
| Fair Price Momentum | 1.41 USD |
| Fair Price DCF | - |
SOL Dividends
No Dividends PaidSOL Growth Ratios
| Growth Correlation 3m | -32.7% |
| Growth Correlation 12m | 10.6% |
| Growth Correlation 5y | -30.3% |
| CAGR 5y | 0.12% |
| CAGR/Max DD 5y | 0.00 |
| Sharpe Ratio 12m | 0.06 |
| Alpha | -39.59 |
| Beta | 1.27 |
| Volatility | 61.61% |
| Current Volume | 176.5k |
| Average Volume 20d | 179.7k |
What is the price of SOL stocks?
As of February 22, 2025, the stock is trading at USD 1.66 with a total of 176,523 shares traded.
Over the past week, the price has changed by -5.14%, over one month by -17.41%, over three months by -8.79% and over the past year by -18.23%.
As of February 22, 2025, the stock is trading at USD 1.66 with a total of 176,523 shares traded.
Over the past week, the price has changed by -5.14%, over one month by -17.41%, over three months by -8.79% and over the past year by -18.23%.
Is Emeren a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Emeren (NYSE:SOL) is currently (February 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -48.60 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SOL as of February 2025 is 1.41. This means that SOL is currently overvalued and has a potential downside of -15.06%.
Probably not. Based on ValueRay Fundamental Analyses, Emeren (NYSE:SOL) is currently (February 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -48.60 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SOL as of February 2025 is 1.41. This means that SOL is currently overvalued and has a potential downside of -15.06%.
Is SOL a buy, sell or hold?
Emeren has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy SOL.
Emeren has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy SOL.
- Strong Buy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for SOL stock price target?
According to ValueRays Forecast Model, SOL Emeren will be worth about 1.7 in February 2026. The stock is currently trading at 1.66. This means that the stock has a potential upside of +1.81%.
According to ValueRays Forecast Model, SOL Emeren will be worth about 1.7 in February 2026. The stock is currently trading at 1.66. This means that the stock has a potential upside of +1.81%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 5 | 201.2% |
| Analysts Target Price | 5 | 201.2% |
| ValueRay Target Price | 1.7 | 1.8% |